15
Aisling Mulligan Healthcare Pricing Office

Aisling Mulligan Healthcare Pricing Office · Asthma hospitalisation rates Diabetes hospitalisation rates Acute Hospital Care In-hospital mortality within 30 days after Acute Myocardial

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Aisling Mulligan Healthcare Pricing Office · Asthma hospitalisation rates Diabetes hospitalisation rates Acute Hospital Care In-hospital mortality within 30 days after Acute Myocardial

Aisling Mulligan

Healthcare Pricing Office

Page 2: Aisling Mulligan Healthcare Pricing Office · Asthma hospitalisation rates Diabetes hospitalisation rates Acute Hospital Care In-hospital mortality within 30 days after Acute Myocardial
Page 3: Aisling Mulligan Healthcare Pricing Office · Asthma hospitalisation rates Diabetes hospitalisation rates Acute Hospital Care In-hospital mortality within 30 days after Acute Myocardial
Page 4: Aisling Mulligan Healthcare Pricing Office · Asthma hospitalisation rates Diabetes hospitalisation rates Acute Hospital Care In-hospital mortality within 30 days after Acute Myocardial

Each national collection holds arich source of data. In order togain the greatest benefit from thedata, it needs to be accessibleand used. National datacollections have an obligation tomake sure that the use of theirdata is optimised to achieve thebest value for money, and providethe greatest benefit to users inorder to maximise health gain.

Page 5: Aisling Mulligan Healthcare Pricing Office · Asthma hospitalisation rates Diabetes hospitalisation rates Acute Hospital Care In-hospital mortality within 30 days after Acute Myocardial

A key principle underpinning the work of the Office would be that, at the hospital level, data should be collected and transmitted once but then used for multiple purposes by different strategic stakeholders.

Page 6: Aisling Mulligan Healthcare Pricing Office · Asthma hospitalisation rates Diabetes hospitalisation rates Acute Hospital Care In-hospital mortality within 30 days after Acute Myocardial

� Measuring Quality

� Clinical Audit

� Investigation

� Health Technology Assessment

� Policy

� Research

Page 7: Aisling Mulligan Healthcare Pricing Office · Asthma hospitalisation rates Diabetes hospitalisation rates Acute Hospital Care In-hospital mortality within 30 days after Acute Myocardial

Supporting People with Long Term Conditions Supporting People with Long Term Conditions Supporting People with Long Term Conditions Supporting People with Long Term Conditions

� COPD hospitalisation rates

� Asthma hospitalisation rates

� Diabetes hospitalisation rates

Acute Hospital Care Acute Hospital Care Acute Hospital Care Acute Hospital Care

� In-hospital mortality within 30 days after Acute Myocardial Infarction (AMI)

� In-hospital mortality within 30 days after haemorrhagic stroke

� In-hospital mortality within 30 days after ischaemic stroke

� In-hospital waiting time for hip fracture surgery

� The data presented for this indicator are based on analysis of HIPE data carried out by the Department of Health using the definitions and methodology developed by the OECD Health Care Quality Indicators (HCQI) project.

Page 8: Aisling Mulligan Healthcare Pricing Office · Asthma hospitalisation rates Diabetes hospitalisation rates Acute Hospital Care In-hospital mortality within 30 days after Acute Myocardial

� The central aim of all NOCA audit streams is to improve clinical services for patients in Ireland.

Page 9: Aisling Mulligan Healthcare Pricing Office · Asthma hospitalisation rates Diabetes hospitalisation rates Acute Hospital Care In-hospital mortality within 30 days after Acute Myocardial

� The Authority may undertake or be required by the Minister to undertake an investigation into the safety, quality and standard of healthcare services, if there is a serious risk to the health and welfare of service users.

Page 10: Aisling Mulligan Healthcare Pricing Office · Asthma hospitalisation rates Diabetes hospitalisation rates Acute Hospital Care In-hospital mortality within 30 days after Acute Myocardial

� HTA is a form of research that generates information about the clinical and cost-effectiveness of health technologies

Page 11: Aisling Mulligan Healthcare Pricing Office · Asthma hospitalisation rates Diabetes hospitalisation rates Acute Hospital Care In-hospital mortality within 30 days after Acute Myocardial
Page 12: Aisling Mulligan Healthcare Pricing Office · Asthma hospitalisation rates Diabetes hospitalisation rates Acute Hospital Care In-hospital mortality within 30 days after Acute Myocardial

� Support research, information and evidence that meet the needs and challenges of the Irish health and social care system

Page 13: Aisling Mulligan Healthcare Pricing Office · Asthma hospitalisation rates Diabetes hospitalisation rates Acute Hospital Care In-hospital mortality within 30 days after Acute Myocardial

� Planning & MeasurementPlanning & MeasurementPlanning & MeasurementPlanning & Measurement

� Clinical Strategy and Programmes Clinical Strategy and Programmes Clinical Strategy and Programmes Clinical Strategy and Programmes

� InternationallyInternationallyInternationallyInternationally

Page 14: Aisling Mulligan Healthcare Pricing Office · Asthma hospitalisation rates Diabetes hospitalisation rates Acute Hospital Care In-hospital mortality within 30 days after Acute Myocardial

� Knowledge and Information Plan

� Individual Health Identifier

� Health Information Bill

Page 15: Aisling Mulligan Healthcare Pricing Office · Asthma hospitalisation rates Diabetes hospitalisation rates Acute Hospital Care In-hospital mortality within 30 days after Acute Myocardial